UNSPSC 51412800: Vasodilator ketones

Vasodilator drugs made from organic compounds with the structure RC(=O)R.

UNSPSC 51412800 Vasodilator ketones is a Class code that covers emergency medications and pharmaceutical products for advanced life support and acute care interventions, as evidenced by recent state and local solicitations for epinephrine, adenosine, diltiazem, and labetalol compounds used in prehospital and hospital settings. State and local governments procure under this code through fire rescue departments, health and human services agencies, cooperative purchasing alliances, and multistate pharmacy benefit programs that supply emergency medications and generic pharmaceuticals to public safety, healthcare, and state employee populations. The City of Tampa Fire Rescue, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the diversity of issuing bodies — ranging from municipal public safety departments to state health agencies to regional cooperative purchasing vehicles. Purchases typically include strict quality and compliance requirements: medications must maintain minimum shelf-life windows (nine months or more at point of delivery, or one year from manufacture), vendors must comply with FDA requirements, Good Manufacturing Practices (cGMP), Drug Supply Chain Security Act (DSCSA) certification, OSHA Hazard Communication Standards, and Section 508 accessibility standards. Contracts often include performance penalties, insurance requirements (commercial general liability, network security and privacy liability, professional liability), and firm pricing that includes shipping, freight, and applicable taxes.

Recent activity spans Florida and a multistate cooperative anchored in Minnesota serving Oregon and other jurisdictions. The City of Tampa issued IFB 26P00188 for Advanced Life Support Medications (Adenosine, Epinephrine, Diltiazem, Labetalol) with a response deadline of April 8, 2026 and an estimated contract value of $40,000, awarded to the lowest responsive bidder with a one-year term and two optional one-year renewals, plus SLBE sheltered-market designation with a 5 percent bid discount. The Minnesota Department of Administration's MMCAP issued RFP S1070000015802 for Generic Multi Source Pharmaceuticals and OTC Products with a response deadline of March 26, 2026, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, Morris & Dickson) with awards effective July 1, 2026 for a two-year term; evaluation weighted 75 percent on price competitiveness, 10 percent on fixed pricing, 5 percent each on administrative compliance, EDI capability, and administrative fee agreement. The Texas HHS Commission issued RFI HHS0017013 in March 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional PBM, GPO, and wholesaler channels, representing early-stage market intelligence gathering for a future formal solicitation.